Sangamo Therapeutics (SGMO) Revenue & Revenue Breakdown
Sangamo Therapeutics Revenue Highlights
Latest Revenue (Y)
$176.23M
Latest Revenue (Q)
$356.00K
Main Segment (Y)
License
Sangamo Therapeutics Revenue by Period
Sangamo Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $176.23M | 58.34% |
| 2022-12-31 | $111.30M | 0.54% |
| 2021-12-31 | $110.70M | -6.34% |
| 2020-12-31 | $118.19M | 15.39% |
| 2019-12-31 | $102.43M | 21.29% |
| 2018-12-31 | $84.45M | 130.95% |
| 2017-12-31 | $36.57M | 88.60% |
| 2016-12-31 | $19.39M | -50.96% |
| 2015-12-31 | $39.54M | -13.80% |
| 2014-12-31 | $45.87M | 90.07% |
| 2013-12-31 | $24.13M | 11.44% |
| 2012-12-31 | $21.66M | 109.86% |
| 2011-12-31 | $10.32M | -50.40% |
| 2010-12-31 | $20.80M | -6.23% |
| 2009-12-31 | $22.19M | 37.08% |
| 2008-12-31 | $16.19M | 77.91% |
| 2007-12-31 | $9.10M | 15.38% |
| 2006-12-31 | $7.88M | 217.43% |
| 2005-12-31 | $2.48M | 88.90% |
| 2004-12-31 | $1.31M | -49.01% |
| 2003-12-31 | $2.58M | -40.62% |
| 2002-12-31 | $4.34M | -11.10% |
| 2001-12-31 | $4.88M | 42.30% |
| 2000-12-31 | $3.43M | 56.05% |
| 1999-12-31 | $2.20M | 7.95% |
| 1998-12-31 | $2.04M | 76.91% |
| 1997-12-31 | $1.15M | 82.28% |
| 1996-12-31 | $632.00K | - |
Sangamo Therapeutics generated $176.23M in revenue during NA 2023, up 58.34% compared to the previous quarter, and up 208.68% compared to the same period a year ago.
Sangamo Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $356.00K | -25.99% |
| 2024-03-31 | $481.00K | -76.44% |
| 2023-12-31 | $2.04M | -78.27% |
| 2023-09-30 | $9.40M | 37.50% |
| 2023-06-30 | $6.83M | -95.67% |
| 2023-03-31 | $157.96M | 480.08% |
| 2022-12-31 | $27.23M | 2.91% |
| 2022-09-30 | $26.46M | -9.93% |
| 2022-06-30 | $29.38M | 4.06% |
| 2022-03-31 | $28.23M | 0.88% |
| 2021-12-31 | $27.99M | -2.02% |
| 2021-09-30 | $28.56M | 2.48% |
| 2021-06-30 | $27.87M | 6.06% |
| 2021-03-31 | $26.28M | 1.86% |
| 2020-12-31 | $25.80M | -55.33% |
| 2020-09-30 | $57.76M | 168.00% |
| 2020-06-30 | $21.55M | 64.83% |
| 2020-03-31 | $13.08M | -76.16% |
| 2019-12-31 | $54.85M | 149.80% |
| 2019-09-30 | $21.96M | 25.13% |
| 2019-06-30 | $17.55M | 117.42% |
| 2019-03-31 | $8.07M | -69.93% |
| 2018-12-31 | $26.84M | 13.90% |
| 2018-09-30 | $23.56M | 10.02% |
| 2018-06-30 | $21.42M | 69.47% |
| 2018-03-31 | $12.64M | -3.36% |
| 2017-12-31 | $13.08M | 10.71% |
| 2017-09-30 | $11.81M | 43.12% |
| 2017-06-30 | $8.25M | 140.96% |
| 2017-03-31 | $3.42M | -61.61% |
| 2016-12-31 | $8.92M | 216.05% |
| 2016-09-30 | $2.82M | -23.74% |
| 2016-06-30 | $3.70M | -6.09% |
| 2016-03-31 | $3.94M | -56.78% |
| 2015-12-31 | $9.12M | 6.44% |
| 2015-09-30 | $8.57M | 2.52% |
| 2015-06-30 | $8.36M | -38.05% |
| 2015-03-31 | $13.49M | -9.77% |
| 2014-12-31 | $14.95M | 20.42% |
| 2014-09-30 | $12.42M | 19.57% |
| 2014-06-30 | $10.38M | 27.96% |
| 2014-03-31 | $8.12M | 18.15% |
| 2013-12-31 | $6.87M | 20.36% |
| 2013-09-30 | $5.71M | -17.70% |
| 2013-06-30 | $6.93M | 49.99% |
| 2013-03-31 | $4.62M | -48.24% |
| 2012-12-31 | $8.93M | 82.03% |
| 2012-09-30 | $4.91M | 7.28% |
| 2012-06-30 | $4.57M | 41.09% |
| 2012-03-31 | $3.24M | -31.72% |
| 2011-12-31 | $4.75M | 155.68% |
| 2011-09-30 | $1.86M | 22.66% |
| 2011-06-30 | $1.51M | -31.18% |
| 2011-03-31 | $2.20M | -53.08% |
| 2010-12-31 | $4.69M | 59.33% |
| 2010-09-30 | $2.94M | -54.90% |
| 2010-06-30 | $6.53M | -1.85% |
| 2010-03-31 | $6.65M | -35.08% |
| 2009-12-31 | $10.24M | 152.06% |
| 2009-09-30 | $4.06M | -14.03% |
| 2009-06-30 | $4.73M | 49.70% |
| 2009-03-31 | $3.16M | -53.80% |
| 2008-12-31 | $6.83M | 82.48% |
| 2008-09-30 | $3.75M | 31.77% |
| 2008-06-30 | $2.84M | 2.78% |
| 2008-03-31 | $2.77M | -0.07% |
| 2007-12-31 | $2.77M | - |
Sangamo Therapeutics generated $356.00K in revenue during Q2 2024, up -25.99% compared to the previous quarter, and up 0.23% compared to the same period a year ago.
Sangamo Therapeutics Revenue Breakdown
Sangamo Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Service | $2.68M | - | - | - | - |
| License and Service | $9.57M | $19.70M | $34.00K | $298.00K | $3.49M |
| License | $132.16M | $37.03M | - | - | - |
| Milestone Achievement | - | $457.00K | $23.00K | $201.00K | $12.82M |
| Research Services | - | $2.13M | $3.06M | $4.82M | $6.37M |
Sangamo Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (91.52%), License and Service (6.63%), and Service (1.86%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License | $481.00K | $114.23M | $5.39M | $1.11M | $11.44M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| License and Service | - | $5.07M | $1.50M | $1.50M | $1.50M | $8.12M | $7.58M | $366.00K | $311.00K | $726.00K | $-1.13M | $206.00K | $227.00K | $326.00K | $321.00K | $380.00K | $-729.00K | $900.00K | $940.00K | $901.00K |
| Research Services | - | - | - | $554.00K | $2.06M | $2.17M | $2.03M | $1.15M | $978.00K | $640.00K | $1.13M | $613.00K | $679.00K | $987.00K | $961.00K | $1.16M | $1.72M | $1.20M | $1.81M | $2.16M |
| Milestone Achievement | - | - | - | - | - | - | - | $247.00K | $210.00K | $490.00K | $-759.00K | $138.00K | $154.00K | $220.00K | $216.00K | $257.00K | $-492.00K | - | - | - |
| Royalty | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Sangamo Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: License (100.00%).
SGMO Revenue FAQ
What is Sangamo Therapeutics’s yearly revenue?
Sangamo Therapeutics's yearly revenue for 2023 was $176.23M, representing an increase of 58.34% compared to 2022. The company's yearly revenue for 2022 was $111.3M, representing an increase of 0.54% compared to 2021. SGMO's yearly revenue for 2021 was $110.7M, representing a decrease of -6.34% compared to 2020.
What is Sangamo Therapeutics’s quarterly revenue?
Sangamo Therapeutics's quarterly revenue for Q2 2024 was $356K, a -25.99% decrease from the previous quarter (Q1 2024), and a -94.79% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $481K, a -76.44% decrease from the previous quarter (Q4 2023), and a -99.70% decrease year-over-year (Q1 2023). SGMO's quarterly revenue for Q4 2023 was $2.04M, a -78.27% decrease from the previous quarter (Q3 2023), and a -92.50% decrease year-over-year (Q4 2022).
What is Sangamo Therapeutics’s revenue growth rate?
Sangamo Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 59.20%, and for the last 5 years (2019-2023) was 72.05%.
What are Sangamo Therapeutics’s revenue streams?
Sangamo Therapeutics's revenue streams in c 23 are Service, License and Service, and License. Service generated $2.68M in revenue, accounting 1.86% of the company's total revenue License and Service generated $9.57M in revenue, accounting 6.63% of the company's total revenue, down -51.43% year-over-year. License generated $132.16M in revenue, accounting 91.52% of the company's total revenue, up 256.89% year-over-year.
What is Sangamo Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Sangamo Therapeutics was License. This segment made a revenue of $132.16M, representing 91.52% of the company's total revenue.